Journal
DIAGNOSTICS
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics11030429
Keywords
endometrial stromal sarcoma; uterine sarcoma; ESN; ESS; EST; LG-ESS; HG-ESS; YWHAE-NUTM2; NTRK-uterine tumours; UUS
Categories
Ask authors/readers for more resources
Endometrial stromal tumours (ESTs) are rare uterine neoplasms with variegated characteristics, classified into four categories based on the latest WHO classification. The clinical behavior and malignant potential vary among different categories. Integrating morphological and molecular findings can aid in therapeutic decision-making for ESTs.
Endometrial stromal tumours (ESTs) are rare, intriguing uterine mesenchymal neoplasms with variegated histopathological, immunohistochemical and molecular characteristics. Morphologically, ESTs resemble endometrial stromal cells in the proliferative phase of the menstrual cycle. In 1966 Norris and Taylor classified ESTs into benign and malignant categories according to the mitotic count. In the most recent classification by the WHO (2020), ESTs have been divided into four categories: Endometrial Stromal Nodules (ESNs), Low-Grade Endometrial Stromal Sarcomas (LG-ESSs), High-Grade Endometrial Stromal Sarcomas (HG-ESSs) and Undifferentiated Uterine Sarcomas (UUSs). ESNs are clinically benign. LG-ESSs are tumours of low malignant potential, often with indolent clinical behaviour, with some cases presented with a late recurrence after hysterectomy. HG-ESSs are tumours of high malignant potential with more aggressive clinical outcome. UUSs show high-grade morphological features with very aggressive clinical behavior. With the advent of molecular techniques, the morphological classification of ESTs can be integrated with molecular findings in enhanced classification of these tumours. In the future, the morphological and immunohistochemical features correlated with molecular categorisation of ESTs, will become a robust means to plan therapeutic decisions, especially in recurrences and metastatic disease. In this review, we summarise the morphological, immunohistochemical and molecular features of ESTs with particular reference to the most recent molecular findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available